Pharma companies announce direct-to-consumer sales and price cuts in USSeveral drug makers are now selling medicines directly to Americans. This move follows President Trump's push to reduce prescription drug p...
TrumpRx website 2025: direct-to-consumer prescription drug platform and Pfizer discount deal explainedPresident Donald Trump announced TrumpRx, a government-operated website launching early 2026 for discounted prescription drugs. Pfizer agre...
Pfizer agrees to lower prescription drug costs for Medicaid in a deal with TrumpPfizer agreed to lower drug costs and invest $70 billion in U.S. manufacturing following a deal with the Trump administration. The drugmake...
Trump may try to force drugmakers to lower some U.S. pricesThe Trump administration is considering a regulatory approach to lower U.S. drug prices, potentially aligning them with those of other weal...
Stop now - 4 medications you should never take with Omega-3 supplements, experts warnOmega-3 supplements are famous for their advantages to heart, brain, and overall health. “Omega-3s are essential fats that act like multita...
Pfizer stock soars as earnings smash expectations, and company raises outlookPFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...
Trump wants to slash prescription drug prices in US. What it means for your pharmacy billDonald Trump has signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines to align with...
Could Trump’s proposed pharmaceutical tariffs trigger a drug shortage in the U.S.?On April 8, President Trump announced that his administration would soon implement a “major tariff on pharmaceuticals” imported into the U....
Could a new policy change the way Americans pay for drugs forever? Trump's new plan revealedThe Trump administration is exploring a policy to link US drug prices to those of other developed nations. This move is causing concern in ...
White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearlyThe Biden administration announced agreements with drug companies to lower the cost of 10 major Medicare medications, potentially saving ta...
Indian Pharma exports: 'USD 10 billion opportunity up for grabs in off patent drug market by 2029'A senior official of the Pharmexcil said drugs such as Merck's Pembrolizumab (Keytruda) whose revenue were at USD 25 billion and Bristol-My...
Cancer drugmaker Bristol Myers to build its largest R&D facility outside US in India by 2025The $100-million facility, inaugurated by Boerner on Monday, is expected to employ over 1,500 employees and will be used to enhance its dru...
Bristol Myers to buy Mirati for $4.8 billionThe purchase will give a boost to Bristol as patent expirations weigh on sales of its oncology medicines. The company had to slash its reve...
US names first 10 drugs for Medicare price negotiationThe Biden administration has released a list of 10 prescription medicines that will be subject to price negotiations by the U.S. Medicare h...
Buy Pfizer, target price Rs 6500: Centrum BrokingPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 25522.43 Crore) operating in Pharmaceuticals ...
Forget the President. Senate may matter more for marketsMany political analysts at this point expect the Democratic Party to remain the majority in the House of Representatives regardless of who ...
HC Bars Cipla, 3 others from launching generic version of Bristol-Myers’ drugDelhi High Court has granted an injunction restraining the domestic pharma companies such as Cipla, Torrent, Emcure, Alkem from selling a m...